208 related articles for article (PubMed ID: 20187783)
1. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
[TBL] [Abstract][Full Text] [Related]
2. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
[TBL] [Abstract][Full Text] [Related]
3. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
[TBL] [Abstract][Full Text] [Related]
4. Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
Yalcin M; Dyskin E; Lansing L; Bharali DJ; Mousa SS; Bridoux A; Hercbergs AH; Lin HY; Davis FB; Glinsky GV; Glinskii A; Ma J; Davis PJ; Mousa SA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1972-80. PubMed ID: 20133461
[TBL] [Abstract][Full Text] [Related]
5. Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.
Yalcin M; Lin HY; Sudha T; Bharali DJ; Meng R; Tang HY; Davis FB; Stain SC; Davis PJ; Mousa SA
Horm Cancer; 2013 Jun; 4(3):176-85. PubMed ID: 23456390
[TBL] [Abstract][Full Text] [Related]
6. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
7. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
Davis PJ; Davis FB; Mousa SA; Luidens MK; Lin HY
Annu Rev Pharmacol Toxicol; 2011; 51():99-115. PubMed ID: 20868274
[TBL] [Abstract][Full Text] [Related]
8. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.
Rebbaa A; Chu F; Davis FB; Davis PJ; Mousa SA
Angiogenesis; 2008; 11(3):269-76. PubMed ID: 18386142
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.
Sudha T; Bharali DJ; Sell S; Darwish NHE; Davis PJ; Mousa SA
Horm Cancer; 2017 Jun; 8(3):157-165. PubMed ID: 28396979
[TBL] [Abstract][Full Text] [Related]
10. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Rajabi M; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2018 Apr; 28(7):1223-1227. PubMed ID: 29519736
[TBL] [Abstract][Full Text] [Related]
12. Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor.
Lee S; Kim J; Shim G; Kim S; Han SE; Kim K; Kwon IC; Choi Y; Kim YB; Kim CW; Oh YK
J Control Release; 2012 Dec; 164(2):213-20. PubMed ID: 22664473
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, Biodistribution, and Anti-Angiogenesis Efficacy of Diamino Propane Tetraiodothyroacetic Acid-conjugated Biodegradable Polymeric Nanoparticle.
Li W; Yalcin M; Bharali DJ; Lin Q; Godugu K; Fujioka K; Keating KA; Mousa SA
Sci Rep; 2019 Jun; 9(1):9006. PubMed ID: 31227723
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
Lin HY; Landersdorfer CB; London D; Meng R; Lim CU; Lin C; Lin S; Tang HY; Brown D; Van Scoy B; Kulawy R; Queimado L; Drusano GL; Louie A; Davis FB; Mousa SA; Davis PJ
PLoS Comput Biol; 2011 Feb; 7(2):e1001073. PubMed ID: 21304935
[TBL] [Abstract][Full Text] [Related]
15. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
Schmohl KA; Müller AM; Wechselberger A; Rühland S; Salb N; Schwenk N; Heuer H; Carlsen J; Göke B; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2015 Dec; 22(6):941-52. PubMed ID: 26307023
[TBL] [Abstract][Full Text] [Related]
18. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
Davis PJ; Lin HY; Hercbergs A; Mousa SA
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
[TBL] [Abstract][Full Text] [Related]
19. Cell-surface receptor for thyroid hormone and tumor cell proliferation.
Davis PJ; Davis FB; Lin HY; Bergh JJ; Mousa S; Hercbergs A; Fenstermaker RA; Ciesielski MJ
Expert Rev Endocrinol Metab; 2006 Nov; 1(6):753-761. PubMed ID: 30754150
[TBL] [Abstract][Full Text] [Related]
20. The induction of myeloma cell death and DNA damage by tetrac, a thyroid hormone derivative.
Cohen K; Abadi U; Hercbergs A; Davis PJ; Ellis M; Ashur-Fabian O
Endocr Relat Cancer; 2018 Jan; 25(1):21-34. PubMed ID: 29018054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
